WallStreetZenWallStreetZen

NYSEMKT: ATNM
Actinium Pharmaceuticals Inc Stock

Buy ATNM
$5.41-0.06 (-1.1%)
Updated Aug 9, 2022
ATNM Price
$5.41
Fair Value Price
N/A
Market Cap
$128.67M
52 Week Low
$4.41
52 Week High
$10.30
P/E
-4.75x
P/B
1.87x
P/S
77.4x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.46M
Earnings
-$24.58M
Gross Margin
100%
Operating Margin
-1,681.46%
Profit Margin
-1,681.5%
Debt to Equity
0.08
Operating Cash Flow
-$21M
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ATNM Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATNM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATNM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ATNM is good value based on its book value relative to its share price (1.87x), compared to the US Biotechnology industry average (4.77x)
P/B vs Industry Valuation
ATNM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ATNM due diligence checks available for Premium users.

Valuation

ATNM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.75x
Industry
-5.67x
Market
32.55x

ATNM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.87x
Industry
4.77x
ATNM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATNM's financial health

Profit margin

Revenue
$940.0k
Net Income
-$5.1M
Profit Margin
-545.6%
ATNM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ATNM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$74.6M
Liabilities
$5.7M
Debt to equity
0.08
ATNM's short-term assets ($74.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATNM's short-term assets ($74.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATNM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ATNM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.8M
Investing
-$7.0k
Financing
-$22.0k
ATNM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATNM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATNM$128.67M-1.10%-4.75x1.87x
VIRX$130.08M-12.15%-3.18x1.52x
HOWL$126.93M-15.00%-1.16x0.91x
TCRR$130.49M+0.90%-1.13x0.58x
EPIX$130.90M-4.50%-4.45x0.98x

Actinium Pharmaceuticals Stock FAQ

What is Actinium Pharmaceuticals's quote symbol?

NYSEMKT: ATNM) Actinium Pharmaceuticals trades on the NYSEMKT under the ticker symbol ATNM. Actinium Pharmaceuticals stock quotes can also be displayed as NYSEMKT: ATNM.

If you're new to stock investing, here's how to buy Actinium Pharmaceuticals stock.

What is the 52 week high and low for Actinium Pharmaceuticals (NYSEMKT: ATNM)?

(NYSEMKT: ATNM) Actinium Pharmaceuticals's 52-week high was $10.30, and its 52-week low was $4.41. It is currently -47.48% from its 52-week high and 22.68% from its 52-week low.

How much is Actinium Pharmaceuticals stock worth today?

(NYSEMKT: ATNM) Actinium Pharmaceuticals currently has 23,784,506 outstanding shares. With Actinium Pharmaceuticals stock trading at $5.41 per share, the total value of Actinium Pharmaceuticals stock (market capitalization) is $128.67M.

Actinium Pharmaceuticals stock was originally listed at a price of $45.00 in Dec 27, 2012. If you had invested in Actinium Pharmaceuticals stock at $45.00, your return over the last 9 years would have been -87.98%, for an annualized return of -20.97% (not including any dividends or dividend reinvestments).

How much is Actinium Pharmaceuticals's stock price per share?

(NYSEMKT: ATNM) Actinium Pharmaceuticals stock price per share is $5.41 today (as of Aug 9, 2022).

What is Actinium Pharmaceuticals's Market Cap?

(NYSEMKT: ATNM) Actinium Pharmaceuticals's market cap is $128.67M, as of Aug 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Actinium Pharmaceuticals's market cap is calculated by multiplying ATNM's current stock price of $5.41 by ATNM's total outstanding shares of 23,784,506.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.